- Most Recent Funding
- $2 Million Seed on August 7, 2013
Carmenta Bioscience, Inc., is a privately held medical technology company dedicated to improving maternal and fetal health. Spun-out of Stanford University School of Medicine in 2012, Carmenta Bioscience is currently developing a highly accurate, serum-based diagnostic test for preeclampsia.
Current Team (4)Update
Board Members and Advisors (2)Update
Palo Alto, CA 94301
- 09/23/13 -biocentury.com
- 01/25/13 -businesswire.com